Abstract:Objective To modified doxorubicin liposome with transferrin(TF),and to investigate its inhibition efficacy on the proliferation of human breast cancer cells.Methods The liposome was prepared by thin film ultrasonic,and doxorubicin liposomal was prepared by sulfuric acid gradient.The TF-doxorubicin lipo-some was prepared by the post insertion method.The uptake of TF-liposomal doxorubicin on breast cancer cells MCF-7 and MDA-MB-231 were detected by confocal microscopy.The killing ability of TF-doxorubicin liposomal targeting for MCF-7 and MDA-MB-231 were detected by MTT assay.Inhibitory effect of TF-doxorubicin lipo-some on the growth of MCF-7 and MDA-MB-231 were detected by soft agar colony assay.Results Confocal microscopy result showed that the uptake of TF-liposomal doxorubicin on MCF-7 and MDA-MB-231 were signifi-cantly higher than doxorubicin liposomal.Cell-killing ability on MCF-7 and MDA-MB-231 showed that the IC50 in TF-liposomal doxorubicin [MCF-7 cells:(20.8 ±3.2)μmol/L;MDA-MB-231 cells:(20.1 ±3.0)μmol/L)] were significantly lower than the liposomal [(1 58.6 ±24.6)μmol/L;(1 60.1 ±25.1 )μmol/L)]and free doxorubicin [(1 61 .7 ±26.2)μmol/L;(1 66.9 ±27.0)μmol/L)],with significant differences(F =1 1 6.03, P <0.001 ;F =75.29,P <0.001 ).Soft agar colony assay showed that the inhibition of TF-doxorubicin lipo-some on colony growth were significantly higher than doxorubicin liposome,free doxorubicin and control [dia-meter of MDA-MB-231 cells:(60.5 ±10.4)μm,(94.3 ±16.8)μm,(1 31 .8 ±22.6)μm,(162.8 ±30.3)μm;diameter of MCF-7 cells:(31 .8 ±5.5)μm,(62.1 ±11 .1 )μm,(108.6 ±1 8.6)μm,157.4 ±29.3)μm],with significant differences (F =87.17,P <0.000 1 ;F =178.23,P <0.000 1 ).Conclusion TF-doxorubicin lipo-some has a significant inhibitory effect on the proliferation of breast cancer cells in vitro,and can effectively and specifically kill the breast cancer cells,which provides theoretical basis for the treatment of breast cancer in vivo.

Preparation of adriamycin liposome coupled with HTf(Fe)<sub>2</sub> and its anti-tumor activity on human hepatoma cell line SMMC-7721

Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy.

Comparison of the Anti-Tumour Activity Between N-trimethyl Chitosan-Coated Adriamycin Liposomes and Regular Adriamycin Liposomes

Evaluation of in vivo Tumor Angiogenesis Targeting of Adriamycin Cationic Liposomes Coated by N-trime-thyl Chitosan

Anti-hepatoma Human Single-Chain Fv Antibody and Adriamycin Conjugates with Potent Antitumor Activity

Preparation of Adriamycin Liposomes Conjugated with VEGF and Its Targeting Action on Human Tumor-Derived Vascular Endothelial Cells in Vitro

[Preparation and in Vitro Killing Effect of Adriamycin-Loaded Immunonanosphere Against Hepatoma Led by F (ab')2 Fragment of Monoclonal Antibodies].

Antitumor efficacy of adriamycin encapsulated in liposomes in mice

Preparation of Adriamycin Liposomes Coated by N-trimethyl Chitosan

Inhibition of Tumor Growth by Recombinant Adenovirus Containing Human Lactoferrin Through Inducing Tumor Cell Apoptosis in Mice Bearing Emt6 Breast Cancer

Study of Transferrin Modified Doxorubicin Liposome Targeted to Inhibit Proliferation of Breast Cancer Cells

Enhanceing Antitumor Effect of Adriamycin Nanoparticle - Lipiodol Emulsion by Pretreating Tumor Cells with Diethyldithiocarbamate

Preparation and antitumor evaluation of hinokiflavone hybrid micelles with mitochondria targeted for lung adenocarcinoma treatment

Preparation of Adriamycin Magnetic Albumin Microspheres and Their Experimental Antitumor Effects in Vitro and in Vivo.

Combination of Human Fas (CD95/Apo-1) Ligand with Adriamycin Significantly Enhances the Efficacy of Antitumor Response

Studies on preparation and pharmaceutical features of human hepatoma-specific immunomicrospheres

Inhibitory effect of combined tacrolimus and adriamycin on hepatocellular carcinoma:an experimental study

Preparation and properties of tumor-targeting lentinan-oleic acid polymer micelles based on folic acid for adriamycin delivery

Preparation and Anti-tumor Activity Evaluation of LyP-1-conjugated Liposomes for Tumor Targeting Drug Delivery

Effect of Mycophenolate Mofetil Plus Adriamycin on HepG-2 Cells.

Primary Studies on Preparation and Activity of Liposomal Adriamycin